Shared publicly  - 
Shkreli is the CEO of Retrophin, but he’s probably better known as the manager of MSMB. In that role, he has taken a vocal stand against a number of life sciences companies that he believes are not being managed properly, and he has even encouraged investors to bet the share prices of those firms would drop by “shorting” their stocks.
Add a comment...